International Myeloma Society Myeloma Cure Summit Definitions, Metrics, and Milestones 2026

• Include:  videos + file sub vtt +  pdf, size:  GB
• Target Audience: Hematologists, Medical Oncologists, Immunologists, Radiologists
• Sample video: contact me for sample video
• Information:

Learning Objectives

To evaluate key parameters in myeloma, including the depth and durability of minimal residual disease (MRD) negativity.

To assess the roles of advanced imaging and mass spectrometry in defining a cure.

To understand immune reconstitution, time off therapy, and the restoration of normal function.

To explore the potential reversion to an MGUS-like state under the guidance of leading investigators and clinicians.

To examine patient sub-group considerations, such as age and disease risk, to determine who is most likely to be cured.

To identify specific therapies and concepts that are potentially able to increase cure fractions.

Target Audience

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Best for Hematologists, Medical Oncologists, Immunologists, Radiologists, and Clinical Researchers.

Topics

February 20, 2026

February 21, 2026

Panel/Participants: Kenneth Anderson, Shaji Kumar, Maria-Victoria Mateos, Nikhil Munshi, Philippe Moreau, Noopur Raje, Jesus San Miguel